Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evolution of the CANDA at Roche

O Rutman1, S V Givens

  • 1Hoffmann-La Roche Inc., Nutley, New Jersey 07110, USA.

Journal of Biopharmaceutical Statistics
|November 14, 1997
PubMed
Summary

Computer-assisted New Drug Applications (CANDAs) are becoming more valuable for internal researchers, not just regulators. Future enhancements will improve their utility in the drug development process.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients.

Cancer·2001
Same author

Evaluation of methods of administering tyramine to raise systolic blood pressure.

Clinical pharmacology and therapeutics·1988
Same author

Effect of oral cibenzoline on steady-state digoxin concentrations in healthy volunteers.

Journal of clinical pharmacology·1988
Same author

Trimoprostil plasma concentration-gastric acid inhibition relationships in duodenal ulcer patients.

Journal of clinical pharmacology·1986
Same author

Trimoprostil plasma concentration--gastric acid inhibition relationships: potentiation by food.

Clinical pharmacology and therapeutics·1985
Same author

Toxic effects of lasalocid in horses.

American journal of veterinary research·1981

Area of Science:

  • Pharmacovigilance
  • Regulatory Science
  • Data Management

Background:

  • Computer-assisted New Drug Applications (CANDAs) have evolved from regulatory tools to internal research instruments.
  • Current CANDA systems face challenges in usability, documentation, and validation for internal use.
  • The data summary, display, and query functions represent the most complex aspect of CANDA systems.

Purpose of the Study:

  • To describe Roche's current CANDA system and its in-house usability features.
  • To outline the challenges associated with using, documenting, and validating CANDA systems.
  • To present Roche's future vision for CANDA, including strategies, targets, and expected savings.

Main Methods:

  • Description of Roche's existing CANDA system.
  • Analysis of challenges in CANDA implementation and validation.
  • Outline of future CANDA development strategies.

Main Results:

  • Roche's current CANDA system offers features for in-house usability.
  • Significant challenges exist in the practical application, documentation, and validation of CANDA systems.
  • The data handling components of CANDA are particularly complex.

Conclusions:

  • CANDAs are transitioning towards greater internal utility beyond regulatory compliance.
  • Addressing usability, documentation, and validation challenges is crucial for maximizing CANDA benefits.
  • Roche is strategically planning future CANDA enhancements to increase efficiency and achieve cost savings.

Related Experiment Videos